Clinical Trial Update: Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

View source ↗

Summary

A long-term follow-up study for subjects with chronic hepatitis B previously treated with Imdusiran (AB729) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Imdusiran (AB-729)

Snippet

Sponsor: Arbutus Biopharma Corporation | Conditions: Long Term Follow-up | Status: RECRUITING